1-2 of 2
Jaroslaw Maciejewski
Close
Sort by
Journal Articles

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

Amy E. DeZern, Johannes B. Goll, R. Coleman Lindsley, Rafael Bejar, Steffanie H. Wilson, Donnie Hebert, Joachim Deeg, Ling Zhang, Steven Gore, Tareq Al Baghdadi, Jaroslaw Maciejewski, Jane Liu, Eric Padron, Rami Komrojki, Wael Saber, Gregory Abel, Steven H. Kroft, Alexandra Harrington, Tyler Grimes, Harrison Reed, Robert S. Fulton, Nancy L. DiFronzo, Nancy Gillis, Mikkael A. Sekeres, Matthew J. Walter
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3749–3759.
https://doi.org/10.1182/bloodadvances.2022008578
Published: 2023
Includes: Supplemental data
Journal Articles

NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy

Clinical Trials & Observations
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Koji Sasaki, Keyur Patel, Irene Ganan-Gomez, Elias Jabbour, Tapan Kadia, Farhad Ravandi, Courtney DiNardo, Gautham Borthakur, Koichi Takahashi, Marina Konopleva, Rami S. Komrokji, Amy DeZern, Teodora Kuzmanovic, Jaroslaw Maciejewski, Sherry Pierce, Simona Colla, Mikkael A. Sekeres, Hagop Kantarjian, Carlos Bueso-Ramos, Guillermo Garcia-Manero
Journal: Blood Advances
Blood Adv (2019) 3 (6): 922–933.
https://doi.org/10.1182/bloodadvances.2018026989
Published: 2019
Includes: Supplemental data